Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Moderna, Inc. (MRNA) – Moderna, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Moderna (MRNA) trades at $49.04, down 2.74% on the day, but remains near the analyst consensus price target of $50.20. The stock shows a bullish technical signal, with the current price near key support at $49. Recent Q1 2026 results delivered a significant revenue beat ($389M vs. $130.62M est.) driven by strong international COVID-19 vaccine sales, though a large litigation charge widened the net loss. Positive Phase 3 data for its mRNA flu vaccine (mRNA-1010) published in May 2026 provides a key pipeline catalyst.
The outlook is a mix of promising pipeline progress against persistent financial losses. The flu vaccine success and reiterated 2026 revenue growth guidance of up to 10% offer potential catalysts. However, the company continues to burn cash with negative net income margins (-144.92% in 2026) and relies on investment inflows to fund operations. The primary investment opportunity is the successful commercialization of new mRNA products beyond COVID-19, while the main risk is the timeline to profitability amid high R&D spending.
Read full analysis

Key Stats

  • Market Cap
    $19.85B
  • Sector
    Health
  • 3M Drawdown
    -21.51%
  • Enterprise Value
    $15.94B
  • Dividend Yield
    -
  • Trading Activity
    26% Buy | 74% Sell
  • Typical Hold Time
    69 days
$49.04
52W Low: $22.36
20 Nov 2025
52W High: $57.8
04 Mar 2026

Moderna, Inc. (MRNA) is currently valued at a market capitalization of $19.85B, with an enterprise value of $15.94B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -21.51%, reflecting recent price volatility. On average, investors hold Moderna, Inc. for approximately 69 days, indicating typical investor behavior on the platform.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.


Technical Indicators
|
|
|
Overall Summary
Bearish (12)Neutral (10)Bullish (5)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $19.85B
  • Sector
    Health
  • 3M Drawdown
    -21.51%
  • Enterprise Value
    $15.94B
  • Dividend Yield
    -
  • Trading Activity
    26% Buy | 74% Sell
  • Typical Hold Time
    69 days
$49.04
52W Low: $22.36
20 Nov 2025
52W High: $57.8
04 Mar 2026

Moderna, Inc. (MRNA) is currently valued at a market capitalization of $19.85B, with an enterprise value of $15.94B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -21.51%, reflecting recent price volatility. On average, investors hold Moderna, Inc. for approximately 69 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!